Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16048
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGlassford, Neil J-
dc.contributor.authorFrench, Craig J-
dc.contributor.authorBailey, M-
dc.contributor.authorMârtensson, J-
dc.contributor.authorEastwood, Glenn M-
dc.contributor.authorBellomo, Rinaldo-
dc.date.accessioned2016-06-20T05:30:25Z-
dc.date.available2016-06-20T05:30:25Z-
dc.date.issued2016-
dc.identifier.citationCritical Care and Resuscitation 2016; 18(2): 78-88en_US
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/16048-
dc.description.abstractOBJECTIVES:To describe changes in the use of intravenous (IV) fluid by quantity and type in different regions of Australia and New Zealand. DESIGN, SETTING AND PARTICIPANTS: We conducted a retrospective ecological study examining regional and temporal trends in IV fluid consumption across Australia and New Zealand over the periods 2012-2013 and 2013- 2014, using national proprietary sales data as a surrogate for consumption, and demographic data from the public domain. RESULTS: More than 13.3 million litres of IV fluid were consumed in Australia and New Zealand in 2012-2013, and more than 13.9 million litres in 2013-2014, with colloid solutions accounting for < 2%. There was marked regional variation in consumption of fluids, by volumes and proportions used, when standardised to overall Australian and New Zealand values. There was no significant change in the overall volume of crystalloid solutions consumed but there was a significant decrease (9%; P = 0.02) in the ratio of unbalanced to balanced crystalloid solutions consumed. Consumption of all forms of colloid solutions decreased, with a 12% reduction overall (P = 0.02), primarily driven by a 67% reduction in the consumption of hydroxyethyl starch (HES) solutions. CONCLUSIONS: The amount and type of IV fluid use, as determined by fluid sales, is highly variable across Australia and New Zealand. However, overall use of balanced crystalloid solutions is increasing and the use of HES has decreased dramatically.en_US
dc.subjectColloids-
dc.subjectIsotonic Solutions-
dc.subjectFluid Therapy-
dc.titleChanges in intravenous fluid use patterns in Australia and New Zealand: evidence of research translating into practiceen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCritical Care and Resuscitationen_US
dc.identifier.affiliationDepartment of Intensive Care, Austin Health, Melbourne, Victoria, Australiaen
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australiaen
dc.identifier.affiliationDepartment of Intensive Care, Western Health, Melbourne, Victoria, Australiaen
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/27242105en_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptIntensive Care-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

2
checked on Feb 1, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.